Keyphrases
Histopathological Features
100%
Molecular Characteristics
100%
Pseudoprogression
100%
Diffuse Glioma
100%
Tumor
66%
Oligodendroglioma
66%
Mixed Oligoastrocytoma
66%
Contrast Enhancement
50%
TP53 mutation
33%
Chemoradiotherapy
33%
Treatment Effect
33%
Re-resection
33%
IDH mutation
33%
ATRX mutation
33%
Immunohistochemistry
16%
Low Dose Rate
16%
Next-generation Sequencing
16%
Pathologic
16%
Isocitrate Dehydrogenase 1 (IDH1)
16%
Imaging Findings
16%
Glioma
16%
Tumor Progression
16%
Residual Tumor
16%
WHO Grade II
16%
EGFR mutation
16%
1p/19q Codeletion
16%
WHO Grade III
16%
IDH-wildtype
16%
IDH1-R132H
16%
Early Tumor Progression
16%
Medicine and Dentistry
Neoplasm
100%
Ganglioglioma
100%
Oligoastrocytoma
80%
Oligodendroglioma
80%
Chemoradiotherapy
40%
Treatment Effect
40%
Tumor Progression
40%
Surgery
40%
Immunohistochemistry
20%
Epidermal Growth Factor Receptor
20%
Next Generation Sequencing
20%
Biochemistry, Genetics and Molecular Biology
IDH1
100%
Contrast Enhancement
75%
Wild Type
50%
Tumor Progression
50%
Alpha Thalassemia/Mental Retardation X-Linked
50%
Next Generation Sequencing
25%
Epidermal Growth Factor Receptor
25%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Astrocytoma
80%
Oligodendroglioma
80%
Tumor Growth
40%
Chemoradiation Therapy
40%
Epidermal Growth Factor Receptor
20%
Neuroscience
Oligodendroglioma
100%
TP53
50%
Immunohistochemistry
25%
Epidermal Growth Factor Receptor
25%
Immunology and Microbiology
Pseudoprogression
100%
Wild Type
33%
Next Generation Sequencing
16%